Cannabis and adolescence: The current situation in Greece comparing to European and Worldwide context


  • Vasileia Christaki MSc in Strategies of Developmental and Adolescent Health, School of Medicine, National and Kapodistrian
  • Asimina Katrali MSc in Strategies of Developmental and Adolescent Health, School of Medicine, National and Kapodistrian
  • Theodoros N. Sergentanis MSc in Strategies of Developmental and Adolescent Health, School of Medicine, National and Kapodistrian and University of West Attica, Athens


adolescence, cannabis, drug, behavioral disorders, public health


Adolescence is a period of life that makes people vulnerable and prone to illegal substances. They are more likely to commit offenses than any other age group.  In recent years, there has been an increase in the use of cannabis by adolescents worldwide. Cannabis has now been described in several countries, including Greece, as the dominant illegal substance and has been more closely linked to youth culture, as the age of starting cannabis is usually younger than for other drugs. Cannabis has very low acute toxicity and a very small mortality rate compared to other drugs, but morbidity is the most important impact on public health. In many countries, medical cannabis is considered legal in certain specific quantities, but the laws vary from country to country. The use of cannabis is examined and studied on many levels mainly because it affects teenagers in many areas including cognitive, social, and psycho-emotional. Some studies around the world confirm that the earlier and more prolonged exposure to cannabis use, the greater the damage. The fact that it can lead to adverse conditions in adolescents makes it imperative to proceed to primary prevention in the school environment but also in the society of each country. This will properly shape the adolescent's perception of cannabis and help identify other problems that occupy everyday life of adolescents preventing them from starting cannabis use or stop them from continuing using it.


Papageorgiou Ε. Psychiatry. 2nd ed. Athens: Parisianou SA;2009. pp. 297-300

Skandami P, Vetouli M, Kerasioti E, Kafetzopoulos E, Mallioris M. Early intervention for young users of illicit psychoactive substances who present delinquent behavior. Archives of Hellenic medicine 2016, 33(1):115-123. Available from: [accessed 2020 April 16].

Hum A, Robinson L, Jackson A, Ali K. Physician Communication Regarding Smoking and Adolescent Tobacco Use. Pediatrics. 2011;127(6):e1368-e1374.

Mooney-Leber S, Gould T. The long-term cognitive consequences of adolescent exposure to recreational drugs of abuse. Learn Mem. 2018;25(9):481-491.

Therapy Centre for Dependent individuals (KETHEA). Exartisis: Scientific Journal on Addiction Issues. Issue 26, 2016; 13-30

Bossong M, Niesink R. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol. 2010;92(3):370-385.

Tountas Y. Society and health, 5th ed. Odysseas/New Health; 2009

Kokkevi A, Fotiou A, Xanthaki M, Kanavou E. Addictive substances in adolescence. Series of thematic issues: Teenagers, Behaviors & Health. University Research Institute Mental Hygiene. Athens; 2011. Available from: [Accessed 2021 March 10].

Papakosta-Tasopoulou D. Industrial Plants. 2nd ed. Thessaloniki: Modern Education; 2013. pp. 139-152

Cooper M, Hooper C, Thompson M. Mental health of children and teenagers, theory and practice. 1st Ed. Parisianou SA; 2012.

European Monitoring Center for Drugs and Drug Addiction (2019). [Internet]. European Report on Drugs - Trends and Developments. Available from: [Accessed 2020 March 29].

Gifford A, Makriyannis A, Volkow N, Gatley S. In vivo imaging of the brain cannabinoid receptor. Chem Phys Lipids. 2002;121(1-2):65-72.

Wilson R, Nicoll R. Endocannabinoid Signaling in the Brain. Science. 2002;296(5568):678-682.

Ma L, Jia J, Niu W, Jiang T, Zhai Q, Yang L et al. Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions. Sci Rep. 2015;5(1).

Lopez-Quintero C, Cobos J, Hasin D, Okuda M, Wang S, Grant B et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011;115(1-2):120-130.

Simpson A, Magid V. Cannabis Use Disorder in Adolescence. Child and Adolescent Psychiatric Clinics of North America. 2016;25(3):431-443.Simpson AK, Magid V. Cannabis Use Disorder in Adolescence. Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):431-43

World Health Organization [Internet]. Cannabis Available from: [Accessed 2021 Jun 01]

National Organization for Medicine [Internet]. Pharmaceutical Cannabis. Available from: [accessed 2021 Apr 13]

Chen Y, Klig J. Cannabis-related emergencies in children and teens. Curr Opin Pediatr. 2019;31(3):291-296.

University Research Institute of Mental Health (EPIPSY) & National Center for Documentation and Information on Drugs (EKTEPN) [Internet]. The situation of the problem of drugs and alcohol in Greece. Athens; 2017. Available from:

Copeland J, Clement N, Swift W. Cannabis use, harms and the management of cannabis use disorder. Neuropsychiatry. 2014;4(1):55-63.

European Monitoring Center for Drugs and Drug Addiction (2022) [Internet] European Drug Report 2022: Trends and Developments, Publications Office of the European Union, Luxembourg. Available from:

Fotiou A, Kanavou E, Stavrou M, Kokkevi A. The Research Report of the Greek Nationwide School Population Survey on Substance Use and other Addictive Behaviours -ESPAD Greece 2019. Athens, University Mental Health, Neurosciences & Precision Medicine Research Institute “Costas Stefanis” (UMHRI). 2021

Shi Y, Lenzi M, An R. Cannabis Liberalization and Adolescent Cannabis Use: A Cross-National Study in 38 Countries. PLoS ONE. 2015;10(11):e0143562.

Abebe D, Hafstad G, Brunborg G, Kumar B, Lien L. Binge Drinking, Cannabis and Tobacco Use Among Ethnic Norwegian and Ethnic Minority Adolescents in Oslo, Norway. J Immigr Minor Health. 2014;17(4):992-1001.

Sun R, Shek D. Positive Youth Development, Life Satisfaction and Problem Behaviour Among Chinese Adolescents in Hong Kong: A Replication. Soc Indic Res. 2011;105(3):541-559

World Health Organization [Internet]. Mental health status of adolescents in South-East Asia: Evidence for action. New Delhi: Regional Office for South-East Asia; 2017. Available from: [accessed 2021 March 10]

Peltzer K, Pengpid S. Cannabis and Amphetamine Use Among Adolescents in Five Asian Countries. Cent Asian J Glob Health. 2017;6(1).

Harvey M, Sellman J, Porter R, Frampton C. The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev. 2007;26(3):309-319.

Solowij N, Jones K, Rozman M, Davis S, Ciarrochi J, Heaven P et al. Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents. Psychopharmacology. 2011;219(2):575-586.

Patton G, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. BMJ. 2002;325(7374):1195-1198.

Degenhardt L, Coffey C, Carlin J, Swift W, Moore E, Patton G. Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia. Br J Psychiatry. 2010;196(4):290-295.

Paruk S, Burns J. Cannabis and mental illness in adolescents: a review. S Afr Fam Pract. 2015;58(sup1):S18-S21.

Van Ours J, Williams J, Fergusson D, Horwood L. Cannabis use and suicidal ideation. J Health Econ. 2013;32(3):524-537.

Paruk S, Burns J, Caplan R. Cannabis use and family history in adolescent first episode psychosis in Durban, South Africa. J Child Adolesc Ment Health. 2013;25(1):61-68.

National Institute on Drug Abuse [Internet]. Monitoring the Future survey: high school and youth trends.2019 Available from: [accessed 2021 Jan 05]

Dougherty D, Mathias C, Dawes M, Furr R, Charles N, Liguori A et al. Impulsivity, attention, memory, and decision-making among adolescent marijuana users. Psychopharmacology. 2012;226(2):307-319.

Green K, Ensminger M. Adult social behavioral effects of heavy adolescent marijuana use among African Americans. Dev Psychol. 2006;42(6):1168-1178.

Leadbeater B, Ames M, Linden-Carmichael A. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction. 2018;114(2):278-293.

Benjet C, Borges G, Medina-Mora M, Fleiz C, Blanco J, Zambrano J et al. Prevalence and socio-demographic correlates of drug use among adolescents: results from the Mexican Adolescent Mental Health Survey. Addiction. 2007;102(8):1261-1268.

Pyxida. Center for Drug Prevention and Health Promotions. [Internet]. “I know what I'm looking for”- Preventing the use of tobacco, alcohol and other addictive substances in high school students. Available from:

National Institute on Drug Abuse (NIH) [Internet]. DrugFacts: Synthetic Cannabinoids (K2/Spice). Available from:

The European School Survey Project on Alcohol and Other Drugs (ESPAD Group) [Internet]. ESPAD Report 2019: Results from the European School Survey Project on Alcohol and Other Drugs, EMCDDA Joint Publications, Publications Office of the European Union, Luxembourg. 2020. Available from: